Pancreatic cancer is usually found through imaging tests after symptoms appear, because the pancreas sits deep in the abdomen where early tumors cause no warning signs

Most pancreatic cancers are discovered when a person develops symptoms like jaundice (yellowing of the skin and eyes), abdominal pain, or unexplained weight loss, and their doctor orders imaging to investigate. The diagnosis involves a sequence of tests: first imaging to spot a mass, then a biopsy to confirm it is cancer, and finally staging scans to see how far it has spread. This process typically takes weeks, not days, because each test requires scheduling and results take time to process.

The pancreas sits behind the stomach and intestines, which is why tumors can grow large before causing symptoms. By the time most people feel sick enough to see a doctor, the cancer has often progressed beyond the earliest stages. This is why pancreatic cancer has a lower survival rate than many other cancers — not because diagnosis is difficult once symptoms appear, but because symptoms usually arrive late.

Key Takeaways

  • Imaging tests like CT or MRI scans detect a mass in the pancreas, but imaging alone cannot confirm cancer.
  • A biopsy — taking a tissue sample through a needle or during an endoscopy — is required to confirm the diagnosis and identify the cancer type.
  • Staging scans determine whether cancer has spread to the liver, lungs, or other organs, which affects treatment options.
  • Blood tests for tumor markers like CA 19-9 support diagnosis but are not used alone to confirm pancreatic cancer.
  • The entire diagnostic process from first imaging to final staging typically takes three to six weeks.

Imaging tests that detect a pancreatic mass

When a doctor suspects pancreatic cancer based on symptoms, they order imaging to look for a tumor. The most common first test is a CT scan (computed tomography), which takes detailed cross-section images of the abdomen. A CT scan can show the size and location of a mass and whether it appears to involve nearby blood vessels or organs. The scan takes about 10 to 15 minutes and is painless, though you may receive contrast dye through an IV to make the pancreas and surrounding structures more visible.

MRI (magnetic resonance imaging) is another option, particularly useful for detecting whether cancer has spread to the liver. MRI uses magnetic fields instead of radiation and can show soft tissue in fine detail. Some centers use endoscopic ultrasound (EUS), in which a thin tube with an ultrasound probe is passed down the throat and into the stomach, allowing the doctor to image the pancreas from very close range. EUS is especially helpful for small tumors and for obtaining tissue samples.

Imaging can show a suspicious mass, but it cannot prove the mass is cancer. A tumor could be benign, or it could be a cyst or inflammation. That is why a biopsy is always the next step.

Biopsy: confirming cancer and identifying the type

A biopsy means taking a sample of tissue from the pancreas and examining it under a microscope to look for cancer cells. There are several ways to obtain this sample. During an endoscopic ultrasound, the doctor can pass a thin needle through the stomach wall into the pancreas to collect cells — this is called EUS-guided fine-needle aspiration (FNA). The procedure takes 20 to 30 minutes and is usually done with sedation so you are drowsy but awake.

Another approach is CT-guided biopsy, in which the doctor uses CT imaging to guide a needle through the skin into the pancreas. This is done with local anesthesia and takes about 15 to 20 minutes. A third option is ERCP (endoscopic retrograde cholangiopancreatography), a procedure that looks at the bile ducts and pancreatic ducts; during ERCP, the doctor can brush cells from the ducts or take small samples.

The tissue sample is sent to a pathologist, who examines it to confirm whether cancer is present and what type it is. Most pancreatic cancers are adenocarcinoma, which develops from the cells that line the ducts. Results typically come back within one to two weeks. In some cases, if imaging is very typical of cancer and the risk of biopsy is high, doctors may proceed with treatment based on imaging alone, but this is uncommon.

Blood tests that support diagnosis

Blood tests cannot diagnose pancreatic cancer on their own, but they provide supporting information. The most common test is for CA 19-9, a protein that is often elevated in people with pancreatic cancer. However, CA 19-9 can also be elevated in benign conditions like pancreatitis or bile duct obstruction, and some people with pancreatic cancer have normal CA 19-9 levels. The test is more useful for tracking how well treatment is working than for initial diagnosis.

Doctors also check liver function tests, which may show abnormal bilirubin or enzyme levels if the tumor is blocking bile ducts. Blood counts and kidney function are measured to assess overall health before treatment. These tests are routine and help doctors understand the full picture, but the diagnosis rests on imaging and biopsy.

Staging scans: determining how far cancer has spread

Once biopsy confirms cancer, the next step is staging — determining whether the cancer has spread beyond the pancreas. This requires additional imaging. A chest CT looks for tumors in the lungs, since pancreatic cancer commonly spreads there. An abdominal and pelvic CT checks the liver, peritoneum (the lining of the abdomen), and nearby lymph nodes. Some centers also order an MRI of the liver to detect small spots that CT might miss.

Staging determines whether surgery is an option. If the tumor is confined to the pancreas and has not invaded major blood vessels, surgery to remove it may be possible. If cancer has spread to the liver or distant lymph nodes, surgery is usually not recommended, and chemotherapy becomes the primary treatment. Staging scans are typically done within two to three weeks of biopsy confirmation.

How long the diagnostic process takes

The timeline from first symptom to final diagnosis varies, but a typical sequence is: initial imaging (CT or MRI) within one week of seeing a doctor, biopsy scheduled within one to two weeks after imaging, biopsy results back within one to two weeks, and staging scans ordered and completed within another one to two weeks. In total, the process from first imaging to knowing the stage usually takes three to six weeks.

Delays can occur if imaging is unclear and a second test is needed, if biopsy results are inconclusive and a repeat sample is required, or if scheduling conflicts push appointments back. Some centers have faster turnaround than others. If you are waiting for results, asking your doctor's office for an expected timeline can help you understand what to expect.

What happens after diagnosis is confirmed

Once staging is complete, your doctor will discuss treatment options based on the stage and your overall health. If surgery is possible, you may be referred to a pancreatic surgeon. If the cancer has spread, chemotherapy is usually the first treatment. Some people receive chemotherapy before surgery to shrink the tumor. Others receive radiation therapy, either alone or combined with chemotherapy.

Your doctor will also discuss whether you are a candidate for clinical trials testing newer treatments. Pancreatic cancer treatment is evolving, and trials may offer options not yet widely available. Your medical team will explain the goals of treatment — whether it is to remove the cancer, slow its growth, or manage symptoms — and what side effects to expect.

Frequently Asked Questions

Can pancreatic cancer be found before symptoms appear?

Screening for pancreatic cancer in people without symptoms is not routine because no test has been shown to reduce death rates in the general population. People with a strong family history of pancreatic cancer or certain genetic mutations may be offered screening with MRI or endoscopic ultrasound, but this is rare and done only in specialized centers.

Does a biopsy spread cancer cells?

The risk that a biopsy needle spreads cancer is extremely low. Studies have not shown that needle biopsy increases the chance of cancer spreading or worsens outcomes. The benefit of confirming diagnosis and identifying the cancer type far outweighs this theoretical risk.

What if the biopsy result is unclear?

If the first biopsy does not show enough cells or results are inconclusive, a second biopsy may be needed. Sometimes a repeat biopsy using a different method — for example, switching from EUS to CT-guided — provides a clearer sample. Your doctor will discuss whether a repeat biopsy is necessary or whether imaging and clinical findings are enough to proceed with treatment.

How accurate is imaging at detecting pancreatic cancer?

CT and MRI can detect most pancreatic cancers larger than 2 to 3 centimeters, but smaller tumors may be missed. Endoscopic ultrasound is more sensitive for small tumors because the probe is placed close to the pancreas. No imaging test is 100 percent accurate, which is why biopsy confirmation is essential.

Will I need more scans after treatment starts?

Yes. After treatment begins, your doctor will order follow-up imaging — usually CT or MRI — to see whether the tumor has shrunk or stopped growing. The timing depends on the treatment plan, but scans are typically done every two to three months during active treatment and then less frequently afterward.